查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
機器人神經外科市場-全球和區域分析：按應用、產品類型、最終用戶和區域-分析和預測（2025-2035）
市場調查報告書
商品編碼
1753873

機器人神經外科市場-全球和區域分析：按應用、產品類型、最終用戶和區域-分析和預測（2025-2035）

Robotic Neurosurgery Market - A Global and Regional Analysis: Focus on Application, Product Type, End User, and Regional Analysis - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 153 Pages | 商品交期: 1-5個工作天內

價格

預計2023年全球機器人神經外科手術市場規模將達3.348億美元。

預計到2035年，該市場規模將達到22.386億美元，在2025-2035年的預測期內，複合年成長率為16.35%。推動這一成長的關鍵因素包括神經系統疾病盛行率的上升，以及對先進外科手術干預的需求不斷成長。精準度的提升、即時影像的整合以及人工智慧等技術創新正在改善手術效果，並拓展機器人神經外科手術的應用範圍。

主要市場統計數據
預測期 2025-2035
2025年評估 4.924億美元
2035年的預測 22.386億美元
複合年成長率 16.35%

此外，微創手術的興起也推動了該技術的普及，因為它縮短了患者的康復時間並降低了併發症發生率。全球醫療基礎設施的不斷擴張，尤其是在新興市場，進一步推動了市場的成長。此外，研發投入的不斷增加以及產業參與者之間策略聯盟的建立，正在加速產品創新和市場滲透，鞏​​固了機器人神經外科作為醫療保健產業關鍵成長領域的地位。

全球機器人神經外科市場已根據產品類型和臨床應用分類為主要細分市場，以便提供清晰的分析框架和成長機會。產品類型包括機器人系統（實現精準微創手術的核心平台）以及安裝、培訓、維護和軟體更新等基本服務，以確保系統的最佳功能。此外，由專門的手術器械和耗材組成的器械和配件對手術的成功及其持續需求起著至關重要的作用。根據應用，市場分為脊椎神經外科（主要處理與脊椎相關的疾病）和顱神經外科（專注於與大腦和顱骨相關的手術）。按地區分類，市場正在北美、歐洲、亞太地區和世界其他地區擴張。這種細分使行業相關人員能夠了解趨勢、有效分配資源並客製化技術創新以滿足不同外科學科的特定需求，從而利用區域成長。

影響分析：

機器人神經外科手術市場正在產生以下影響：

  • 提高手術精度：機器人系統大大提高了複雜神經外科手術的精確度，從而降低風險並改善患者的治療效果。
  • 微創技術：使用機器人技術可以實現微創手術，從而縮短恢復時間、減少併發症並降低醫療成本。
  • 擴大獲得高級護理的機會：隨著機器人技術的引入，全球更多醫療機構（包括醫療服務不足的地區）現在可以提供尖端神經外科護理。
  • 技術創新和市場成長：不斷的技術進步和不斷增加的投資正在加速新機器人平台和設備的發展，推動市場的強勁擴張。

市場區隔:

細分 1：按產品類型

  • 機器人系統
  • 服務
  • 設備和配件

儀器和配件部分繼續主導機器人神經外科市場（按產品類型）

根據產品類型，機器人腦外科手術市場以儀器和配件為主導，到 2023 年將佔據 51.48% 的佔有率。

細分2：按應用

  • 脊椎神經外科
  • 顱腦神經外科

脊椎神經外科領域將繼續主導機器人神經外科市場（按應用）

根據應用，機器人神經外科市場以脊椎神經外科為主導，到 2023 年將佔 73.51% 的佔有率。

細分 3：按最終用戶

  • 醫院
  • 門診手術中心

醫院部門將繼續主導機器人神經外科手術市場（按最終用戶分類）

根據最終用戶來看，機器人神經外科手術市場由醫院主導，2023 年的佔有率為 91.90%。

細分4：按地區

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 其他亞太國家
  • 其他地區

2023年，亞太地區機器人神經外科手術市場由中國主導，這得益於幾個關鍵因素。這些因素包括醫療基礎設施的快速發展、政府對醫療技術應用的大力支持，以及神經系統疾病盛行率不斷上升的龐大患者群體。此外，研發投入的不斷增加以及人們對微創手術技術的認知和接受度的不斷提高，也推動了對機器人神經外科手術系統的需求。國內領先製造商的湧現以及與全球技術提供商的戰略合作夥伴關係，進一步鞏固了中國在該區域市場的主導地位。

機器人神經外科手術市場的最新趨勢

  • 2025年4月，腦導航生物科技股份有限公司宣布與第一證券公司開始進行首次股票公開發行（IPO）輔導。
  • 2025年3月，神經外科機器人領域的先驅－腦導航生物科技公司宣布與明基醫療科技建立策略夥伴關係，在中國推出並商業化神經外科導航機器人「NaoTrac」。此次合作將支持腦導航生物科技公司2025年的全球化策略，該策略專注於本地夥伴關係，以加快市場進入速度並促進臨床應用。
  • 2024 年 8 月，MMI（Medical Microinstruments, Inc.）宣布成功完成臨床前試驗，以確認 Symani 手術系統在神經外科手術中的可行性。
  • 2024 年 5 月，AiM Medical Robotics Inc. 宣布與布萊根婦女醫院 (BWH) 和哈佛大學手術導航和機器人 (SNR) 實驗室合作，檢驗用於帕金森氏症患者深部腦部刺激治療的先進機器人。
  • 2024 年 5 月，Monteris Medical Corporation 宣布推出專為機器人輔助 NeuroBlate 系統設計的 NeuroBlate NB3 FullFire 1.6mm 雷射探頭。

需求——促進因素與限制因素

市場需求促進因素：

  • 機器人神經外科手術相較於傳統開放性手術的優勢：機器人輔助神經外科手術相比傳統開放性手術具有顯著優勢，已成為現代醫學的顛覆性技術。分析師認為，這些系統是一項重大進步，因為它們提高了手術的精確度和準確度，能夠更精準地定位大腦和脊髓的關鍵區域，從而降低損傷健康組織的風險。機器人手術的微創特性使其切口更小、失血量更少、恢復時間更快、住院時間更短，最終改善病患的預後並降低醫療成本。

此外，機器人系統還能降低傳統開放性手術中常見的腦腫脹、出血和感染疾病等併發症的發生率。由於機器人平台擁有卓越的靈活性和3D視覺化功能，外科醫生也能從更高的效率、更強的控制力和更舒適的體驗中受益。憑藉這些優勢，對機器人神經外科日益成長的需求正在重塑該領域，為患者提供更安全、更有效的治療，同時降低醫療機構的成本。隨著技術的不斷發展，分析師預測，機器人神經外科將成為各種神經外科手術的標準治療方案。

  • 神經系統疾病發生率上升：神經系統疾病發生率上升是影響機器人神經外科市場擴張的重要因素。隨著對先進和微創手術選擇的需求不斷成長，機器人系統將在現代神經外科實踐中發揮關鍵作用，從而改善患者照護和手術效率。根據發表在《刺胳針神經病學》上的一項研究，神經系統疾病是全球疾病和殘疾的主要原因，2021 年影響約 340 萬人。這是過去三十年來的顯著成長，傷殘調整生命年 (DALY) 從 1990 年到 2021 年增加了 18%。造成這項負擔的主要因素包括中風、新生兒腦病變、偏頭痛、阿茲海默症失智症和糖尿病神經病變。值得注意的是，神經發育和兒科疾病佔全球整體負擔的近20%，導致2021年健康壽命損失8,000萬年。

神經系統疾病發生率上升的因素包括人口老化、預期壽命延長以及環境、代謝和生活方式風險因素的影響。令人擔憂的是，超過80%的神經系統疾病死亡和健康損失發生在中低收入國家，凸顯了巨大的健康差距。本研究強調了實施有效的預防、治療、復健和長期照護策略以應對這一日益嚴重的公共衛生問題的重要性。

此類神經系統疾病的盛行率不斷上升，是機器人神經外科市場的主要驅動力。對有效微創治療方案的需求日益成長，推動了機器人輔助神經外科的普及。與傳統的開放性手術相比，這些技術具有更高的精確度、更少的併發症和更快的恢復時間，使其成為現代神經外科實踐的重要組成部分。

市場限制：

  • 高昂的投資成本：實施神經外科機器人的高昂成本是許多醫療機構面臨的經濟障礙，阻礙了這項創新技術的廣泛應用。機器人系統所需的初始投資，以及持續的維護、培訓和營運成本，構成了巨大的預算挑戰，尤其對於規模較小的醫院或財力有限的醫院而言。在考慮機器人系統時，醫院必須仔細評估整體擁有成本，不僅要考慮初始購買價格，還要考慮長期營運成本。

市場機會：

  • 遠距手術機器人系統的發展：遠距手術機器人系統的發展為機器人神經外科市場創造了巨大的機會。透過實現遠端存取專科神經外科護理，這些系統可以克服地理障礙，改善醫療資源匱乏地區和農村地區的醫療服務。先進機器人技術、即時通訊和人工智慧的融合，提高了手術精度，縮短了恢復時間，並為醫院提供了經濟高效的解決方案。此外，世界各地的外科醫生可以進行遠端培訓和協作，從而促進持續創新和知識共用，進一步加速機器人系統的普及。隨著技術的不斷發展，遠距機器人神經外科手術的可能性將不斷擴大，推動市場成長，並重塑全球外科護理的未來。

產品/創新策略：全球機器人神經外科市場已根據產品類型、應用、最終用戶、地區等不同類別進行廣泛細分。這有助於讀者清楚了解哪個細分市場佔有最大佔有率以及哪個細分市場可能在未來幾年內成長。

成長/行銷策略：2022 年 1 月至 2025 年 4 月期間，新產品佔據全球機器人神經外科市場關鍵發展的最大佔有率。

競爭策略：全球機器人神經外科市場擁有許多參與企業，並擁有各自的產品和服務組合。本研究分析並概述了全球機器人神經外科市場的主要企業，包括提供機器人神經外科系統、器械、配件和服務的現有企業。

本報告研究了全球機器人神經外科市場，並概述了市場趨勢以及應用、產品類型、最終用戶、地區和參與市場的公司概況。

目錄

執行摘要

第1章全球機器人神經外科市場：產業展望

  • 趨勢：現況與未來影響評估
    • 機器人神經外科手術的採用率不斷提高
    • 市場參與企業之間的眾多合作
    • 增加產品發布和監管核准
  • 供應鏈概覽
  • 法律規範
    • 美國
    • 歐洲聯盟
    • 英國
    • 日本
    • 中國
    • 其他地區
  • 贖回方案
    • 美國報銷情況
  • 專利分析
    • 專利申請趨勢（按國家和年份）
  • 定價分析
  • 案例研究
  • 資金籌措方案
  • 市場動態

2. 全球機器人神經外科市場（依產品類型），百萬美元，2023-2035

  • 機器人系統
  • 設備和配件
  • 服務

3. 全球機器人神經外科市場（按應用），百萬美元，2023-2035 年

  • 脊椎和神經外科
  • 顱腦神經外科

4. 全球機器人神經外科市場（按最終用戶分類），百萬美元，2023-2035 年

  • 醫院
  • 門診手術中心

5. 全球機器人神經外科市場（按地區分類），百萬美元，2023 年至 2035 年

  • 區域摘要
  • 北美洲
    • 區域概況
    • 市場成長動力
    • 成長抑制因素
    • 手術次數
    • 美國
    • 加拿大
  • 歐洲
    • 區域概況
    • 市場成長動力
    • 成長抑制因素
    • 手術次數
    • 德國
    • 西班牙
    • 英國
    • 其他
  • 亞太地區
    • 區域概況
    • 市場成長動力
    • 成長抑制因素
    • 手術次數
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 其他地區
    • 區域概況
    • 市場成長動力
    • 成長抑制因素
    • 手術次數

第6章 市場-產品概況

  • Medtronic plc
  • Globus Medical, Inc.
  • Renishaw plc
  • Zimmer Biomet Holdings, Inc.

7. 市場競爭基準化分析與公司概況

  • 產品基準
  • 關鍵策略和發展
  • 公司簡介
    • Brainlab AG
    • Renishaw plc
    • Globus Medical, Inc.
    • Zimmer Biomet Holdings, Inc.
    • Medical Microinstruments, Inc.
    • Monteris Medical Corporation
    • Medtronic plc
    • Accuray Incorporated
    • AiM Medical Robotics
    • KUKA AG (Midea Group)
    • Beijing Baihui Weikang Technology Co., Ltd.
    • Brain Navi Biotechnology Co. Ltd
    • Beijing Tinavi Medical Technologies Co., Ltd.

第8章調查方法

Product Code: BHR3021SA

This report can be delivered within 1 working day.

Introduction to Robotic Neurosurgery Market

The global robotic neurosurgery market is projected to reach $2,238.6 million in 2035 and estimated $334.8 million in 2023, growing at a CAGR of 16.35% during the forecast period 2025-2035. Key factors driving this growth include the rising prevalence of neurological disorders, which increases the demand for advanced surgical interventions. Technological innovations, including improved precision, the integration of real-time imaging, and AI-enabled capabilities, are enhancing surgical outcomes and broadening the scope of robotic neurosurgery.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$492.4 Million
2035 Forecast$2,238.6 Million
CAGR16.35%

Additionally, the shift toward minimally invasive procedures has been fueling adoption by reducing patient recovery times and complication rates. The expansion of healthcare infrastructure worldwide, particularly in emerging markets, further supports market growth. Moreover, increased investment in research and development, coupled with strategic collaborations among industry players, has been accelerating product innovation and market penetration, solidifying robotic neurosurgery's role as a key growth sector in the healthcare industry.

Market Introduction

The global robotic neurosurgery market is categorized into key segments based on product type and clinical application to provide a clear framework for analysis and growth opportunities. Product types include robotic systems, the core platforms that enable precise and minimally invasive surgeries, alongside essential services such as installation, training, maintenance, and software updates that ensure optimal system functionality. Additionally, instruments and accessories, comprising specialized surgical tools and consumables, play a critical role in procedure success and ongoing demand. On the application side, the market is primarily divided into spinal neurosurgery, which addresses conditions related to the spine, and cranial neurosurgery, focused on brain and skull-related procedures. Geographically, the market has been expanding across regions including North America, Europe, Asia-Pacific, and the Rest-of-the-World. This segmentation enables industry stakeholders to identify trends, allocate resources effectively, and tailor innovations to meet the specific needs of different surgical domains, thereby capitalizing on regional growth.

Impact Analysis:

The robotic neurosurgery market has made an impact in the following ways:

  • Enhanced Surgical Precision: Robotic systems have significantly improved the accuracy of complex neurosurgical procedures, thereby reducing risks and enhancing patient outcomes.
  • Minimally Invasive Techniques: The adoption of robotics has enabled less invasive surgeries, leading to shorter recovery times, reduced complications, and lower healthcare costs.
  • Expanded Access to Advanced Care: Robotics has facilitated the availability of cutting-edge neurosurgical interventions in more healthcare facilities worldwide, including underserved regions.
  • Innovation and Market Growth: Continuous technological advancements and increased investments have accelerated the development of new robotic platforms and instruments, driving robust market expansion.

Market Segmentation:

Segmentation 1: by Product Type

  • Robotic Systems
  • Services
  • Instruments and Accessories

Instruments and Accessories Segment to Continue Dominating the Robotic Neurosurgery Market (by Product Type)

Based on product type, the robotic neurosurgery market is led by instrument and accessories, which held a 51.48% share in 2023.

Segmentation 2: by Application

  • Spinal Neurosurgery
  • Cranial Neurosurgery

Spinal Neurosurgery Segment to Continue Dominating the Robotic Neurosurgery Market (by Application)

Based on application, the robotic neurosurgery market is led by spinal neurosurgery, which held a 73.51% share in 2023.

Segmentation 3: by End User

  • Hospitals
  • Ambulatory Surgical Centers

Hospitals Segment to Continue Holding its Dominance in the Robotic Neurosurgery Market (by End User)

Based on end users, the robotic neurosurgery market is led by hospitals, which held a 91.90% share in 2023.

Segmentation 4: by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest-of-Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest-of-Asia-Pacific
  • Rest-of-the-World

China dominated the Asia-Pacific robotic neurosurgery market in 2023, driven by several key factors. These include rapid advancements in healthcare infrastructure, strong government support for the adoption of medical technology, and a large patient population with a rising prevalence of neurological disorders. Additionally, increasing investments in research and development, coupled with growing awareness and acceptance of minimally invasive surgical techniques, have fueled demand for robotic neurosurgery systems. The presence of leading domestic manufacturers and strategic partnerships with global technology providers further strengthen China's leadership position in the regional market.

Recent Developments in the Robotic Neurosurgery Market

  • In April 2025, Brain Navi Biotechnology Co., Ltd. announced the commencement of its initial public offering (IPO) counseling with First Securities Inc., a significant move toward tapping into the capital markets to fuel its long-term growth in the surgical robot technology sector.
  • In March 2025, Brain Navi Biotechnology, a pioneer in neurosurgical robotics, revealed a strategic partnership with BenQ Medical Technology to launch and commercialize the NaoTrac neurosurgical navigation robot in China. This collaboration supports Brain Navi's 2025 globalization strategy, focusing on localized partnerships to expedite market entry and boost clinical adoption.
  • In August 2024, MMI (Medical Microinstruments, Inc.) announced the successful completion of a preclinical study that confirmed the feasibility of the Symani Surgical System for neurosurgical procedures.
  • In May 2024, AiM Medical Robotics Inc. announced a collaboration with Brigham and Women's Hospital (BWH) and the Surgical Navigation and Robotics (SNR) Lab at Harvard to validate their advanced robot for deep brain stimulation in Parkinson's patients.
  • In May 2024, Monteris Medical Corporation announced the release of the NeuroBlate NB3 FullFire 1.6mm laser probe, designed for use with their robotic-assisted NeuroBlate system.

Demand - Drivers and Limitations

Market Demand Drivers:

  • Advantages of Robotic Neurosurgical Procedures Over Conventional Open Surgical Procedures: Robotic-assisted neurosurgical procedures offer significant advantages over conventional open surgeries, making them a game-changer in modern medicine. Analysts view these systems as a major advancement due to their enhanced precision and accuracy, which allows for more accurate targeting of critical brain and spinal areas, reducing the risk of damaging healthy tissues. The minimally invasive nature of robotic surgeries results in smaller incisions, reduced blood loss, faster recovery times, and shorter hospital stays, ultimately improving patient outcomes and lowering healthcare costs.

Additionally, robotic systems reduce the likelihood of complications such as brain swelling, bleeding, and infections, which are common in traditional open surgeries. Surgeons also benefit from improved efficiency, greater control, and enhanced comfort, as robotic platforms offer superior dexterity and 3D visualization. With these advantages, the growing demand for robotic neurosurgery has been reshaping the field, offering patients safer, more effective treatments while driving cost savings for healthcare providers. As technology continues to evolve, analysts predict that robotic neurosurgery will become the standard of care for a wide range of neurological procedures.

  • Rising Prevalence of Neurological Disorders: The rising incidence of neurological conditions has been significantly influencing the expansion of the robotic neurosurgery market. As the demand for advanced, minimally invasive surgical options continues to grow, robotic systems are poised to play a crucial role in modern neurosurgical practices, thereby enhancing patient care and surgical efficiency. The study published in The Lancet Neurology reveals that neurological conditions have become the leading cause of ill health and disability globally, affecting approximately 3.4 million people in 2021. This marks a significant increase over the past three decades, with the number of disability-adjusted life years (DALYs) rising by 18% from 1990 to 2021. The primary contributors to this burden include stroke, neonatal encephalopathy, migraine, Alzheimer's disease and other dementias, and diabetic neuropathy. Notably, neurodevelopmental and pediatric conditions accounted for nearly 20% of the total neurological burden worldwide, equating to 80 million years of healthy life lost in 2021.

The rise in neurological disorders is attributed to factors such as population aging, increased life expectancy, and exposure to environmental, metabolic, and lifestyle risk factors. Alarmingly, over 80% of neurological deaths and health loss occur in low- and middle-income countries, underscoring significant health disparities. The study highlights the importance of implementing effective prevention, treatment, rehabilitation, and long-term care strategies to address this growing public health issue.

This escalating prevalence of neurological conditions is a key driver for the robotic neurosurgery market. The increasing demand for effective and minimally invasive treatment options has spurred the adoption of robotic-assisted neurosurgical procedures. These technologies offer enhanced precision, reduced complications, and shorter recovery times compared to traditional open surgeries, positioning them as a critical component in modern neurosurgical practices.

Market Restraints:

  • High Cost of Investment: The high cost of acquiring neurosurgery robots presents a significant financial hurdle for many healthcare institutions, hindering the widespread adoption of this transformative technology. The initial investment required for robotic systems, along with ongoing maintenance, training, and operational costs, can create a considerable budgetary challenge, particularly for smaller hospitals or those with limited financial resources. As hospitals look to integrate robotic systems, they must carefully assess the total cost of ownership, factoring in not only the upfront purchase price but also the long-term operational expenses.

Market Opportunities:

  • Development of Long-Distance Teleoperated Surgical Robotic Systems: The development of long-distance teleoperated surgical robotic systems presents a significant opportunity for the robotic neurosurgery market. By enabling remote access to specialized neurosurgical care, these systems can overcome geographical barriers, improving healthcare access in underserved and rural regions. The integration of advanced robotics, real-time communication, and artificial intelligence enhances surgical precision, reduces recovery times, and offers cost-effective solutions for hospitals. Moreover, the ability to provide remote training and collaboration among surgeons worldwide fosters continuous innovation and knowledge sharing, further accelerating the adoption of robotic systems. As technology continues to evolve, the potential for long-distance robotic neurosurgery will expand, driving market growth and reshaping the future of surgical care globally.

How can this report add value to an organization?

Product/Innovation Strategy: The global robotic neurosurgery market has been extensively segmented based on various categories, such as product type, application, end user, and region. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Growth/Marketing Strategy: The new offering accounted for the maximum number of key developments in the global robotic neurosurgery market between January 2022 and April 2025.

Competitive Strategy: The global robotic neurosurgery market has numerous established players with product and service portfolios. Key players in the global robotic neurosurgery market, as analyzed and profiled in the study, include established companies offering robotic neurosurgery systems, instruments, accessories, and services.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • Detailed secondary research was performed to ensure maximum coverage of manufacturers/suppliers operational in a country.
  • Exact revenue information, up to a certain extent, was extracted for each company from secondary sources and databases. The revenues specific to the offering, application, end user, and region were then estimated for each market player based on fact-based proxy indicators, as well as primary inputs.
  • The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of robotic neurosurgery.
  • The market contribution of robotic neurosurgery, anticipated to be launched in the future, has been calculated based on historical analysis. This analysis has been supported by proxy factors, including the innovation scale of the companies, funding status, collaborations, customer base, and patent scenario.
  • The scope of availability of robotic neurosurgery products and services in a particular region has been assessed through a comprehensive analysis of companies' prospects, regional end-user perceptions, and other factors influencing the launch of robotic neurosurgery products and services in that region.
  • The base year considered for the calculation of the market size is 2024. A historical year analysis has been done for the period FY2021-FY2023. The market size has been estimated for FY2024 and projected for the period from FY2025 to FY2035.
  • Revenues of the companies have been referenced from their annual reports for FY2021-FY2024. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, product approval status, market collaborations, and operational history.
  • The regional distribution of market revenue has been estimated based on the number of companies in each region and the adoption rate of robotic neurosurgery. All the numbers have been adjusted to a single digit after the decimal for better presentation in the report. However, the real figures have been utilized for compound annual growth rate (CAGR) estimation. The CAGR has been calculated for the period 2025-2035.
  • The market has been mapped based on the available robotic neurosurgery. All the key companies with significant offerings in this field have been considered and profiled in this report.
  • Market strategies and developments of key players have been taken into account for calculating the market potential in the forecast period.

Primary Research:

The primary sources involve industry experts in the robotic neurosurgery market, including the market players offering robotic neurosurgery solutions. Resources, including CXOs, vice presidents, product managers, directors, territory managers, and business development professionals, have been interviewed to gather and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • Validation and triangulation of all the numbers and graphs
  • Validation of the report's segmentation and key qualitative findings for robotic neurosurgery
  • Understanding the competitive landscape and business model
  • Current and proposed production values of a product by market players
  • Validation of the numbers of the different segments of the market in focus
  • Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • European Medicines Agency (EMA), American Chemical Society (ACS), Frontiers, World Health Organization (WHO), and National Center for Biotechnology Information (NCBI), among others
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and detailed study of their portfolios
  • Gold standard magazines, journals, whitepapers, press releases, and news articles
  • Databases

The key data points taken from the secondary sources include:

  • Segmentation and percentage share estimates
  • Company and country understanding and data for market value estimation
  • Key industry/market trends
  • Developments among top players
  • Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, type portfolio, and market penetration.

Some prominent names in the global robotic neurosurgery market include:

  • Brainlab AG
  • Renishaw plc
  • Zimmer Biomet Holding, Inc.
  • Medical Microinstruments, Inc.
  • Monteris Medical Corporation
  • Medtronic plc.
  • Globus Medical Inc.
  • Accuray Incorporated

Table of Contents

Executive Summary

Scope and Definition

1 Global Robotic Neurosurgery Market: Industry Outlook

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Increasing Adoption of Robotic Neurosurgery Procedures
    • 1.1.2 Significant Number of Collaborations among Market Players
    • 1.1.3 Growing Number of Product Launch and Regulatory Approvals
  • 1.2 Supply Chain Overview
  • 1.3 Regulatory Framework
    • 1.3.1 U.S.
    • 1.3.2 European Union (EU)
    • 1.3.3 U.K.
    • 1.3.4 Japan
    • 1.3.5 China
    • 1.3.6 Rest-of-the-World (RoW)
  • 1.4 Reimbursement Scenario
    • 1.4.1 Reimbursement Scenario in the U.S.
  • 1.5 Patent Analysis
    • 1.5.1 Patent Filing Trend (by Country, Year)
  • 1.6 Pricing Analysis
  • 1.7 Case Studies
    • 1.7.1 Case Study: First Use of Mazor X Stealth Edition Robotic Guidance Platform at an Outpatient Surgery Center in Ohio
    • 1.7.2 Case Study: Brain Navi's NaoTrac Reaches 100 Neurosurgical Procedures Milestone
  • 1.8 Funding Scenario
  • 1.9 Market Dynamics
    • 1.9.1 Market Drivers
      • 1.9.1.1 Advantages of Robotic Neurosurgical Procedures Over Conventional Open Surgical Procedures
      • 1.9.1.2 Rising Prevalence of Neurological Disorders
      • 1.9.1.3 Continuous Technological Advancements in Robotic Neurosurgery
    • 1.9.2 Market Restraints
      • 1.9.2.1 High Cost of Investment
      • 1.9.2.2 Lack of Skilled Professionals
    • 1.9.3 Market Opportunities
      • 1.9.3.1 Development of Long-Distance Teleoperated Surgical Robotic Systems

2 Global Robotic Neurosurgery Market (by Product Type), $Million, 2023-2035

  • 2.1 Robotic Systems
  • 2.2 Instruments and Accessories
  • 2.3 Services

3 Global Robotic Neurosurgery Market (by Application), $Million, 2023-2035

  • 3.1 Spinal Neurosurgery
  • 3.2 Cranial Neurosurgery

4 Global Robotic Neurosurgery Market (by End User), $Million, 2023-2035

  • 4.1 Hospitals
  • 4.2 Ambulatory Surgical Centers

5 Global Robotic Neurosurgery Market (by Region), $Million, 2023-2035

  • 5.1 Regional Summary
  • 5.2 North America
    • 5.2.1 Regional Overview
    • 5.2.2 Driving Factors for Market Growth
    • 5.2.3 Factors Challenging the Market
    • 5.2.4 Procedure Volume
    • 5.2.5 U.S.
    • 5.2.6 Canada
  • 5.3 Europe
    • 5.3.1 Regional Overview
    • 5.3.2 Driving Factors for Market Growth
    • 5.3.3 Factors Challenging the Market
    • 5.3.4 Procedure Volume
    • 5.3.5 Germany
    • 5.3.6 Spain
    • 5.3.7 U.K.
    • 5.3.8 Rest-of-Europe
  • 5.4 Asia-Pacific
    • 5.4.1 Regional Overview
    • 5.4.2 Driving Factors for Market Growth
    • 5.4.3 Factors Challenging the Market
    • 5.4.4 Procedure Volume
    • 5.4.5 China
    • 5.4.6 Japan
    • 5.4.7 India
    • 5.4.8 Australia
    • 5.4.9 South Korea
    • 5.4.10 Rest-of-Asia-Pacific
  • 5.5 Rest-of-the-World
    • 5.5.1 Regional Overview
    • 5.5.2 Driving Factors for Market Growth
    • 5.5.3 Factors Challenging the Market
    • 5.5.4 Procedure Volume

6 Markets - Product Profiles

  • 6.1 Medtronic plc
    • 6.1.1 Product Overview
    • 6.1.2 Launch Year
    • 6.1.3 Key Features
    • 6.1.4 Key Parameter
    • 6.1.5 Installed Base
    • 6.1.6 Unit Sold
  • 6.2 Globus Medical, Inc.
    • 6.2.1 Product Overview
    • 6.2.2 Launch Year
    • 6.2.3 Key Features
    • 6.2.4 Key Parameter
    • 6.2.5 Installed Base
    • 6.2.6 Unit Sold
  • 6.3 Renishaw plc
    • 6.3.1 Product Overview
    • 6.3.2 Launch Year
    • 6.3.3 Key Features
    • 6.3.4 Key Parameter
    • 6.3.5 Installed Base
    • 6.3.6 Unit Sold
  • 6.4 Zimmer Biomet Holdings, Inc.
    • 6.4.1 Product Overview
    • 6.4.2 Launch Year
    • 6.4.3 Key Features
    • 6.4.4 Key Parameter
    • 6.4.5 Installed Base
    • 6.4.6 Unit Sold

7 Markets - Competitive Benchmarking & Company Profiles

  • 7.1 Product Benchmarking
  • 7.2 Key Strategies and Development
  • 7.3 Company Profiles
    • 7.3.1 Brainlab AG
      • 7.3.1.1 Overview
      • 7.3.1.2 Top Products/Product Portfolio
      • 7.3.1.3 Top Competitors
      • 7.3.1.4 Target Customers
      • 7.3.1.5 Key Personal
      • 7.3.1.6 Analyst View
    • 7.3.2 Renishaw plc
      • 7.3.2.1 Overview
      • 7.3.2.2 Top Products/Product Portfolio
      • 7.3.2.3 Top Competitors
      • 7.3.2.4 Target Customers
      • 7.3.2.5 Key Personal
      • 7.3.2.6 Analyst View
    • 7.3.3 Globus Medical, Inc.
      • 7.3.3.1 Overview
      • 7.3.3.2 Top Products/Product Portfolio
      • 7.3.3.3 Top Competitors
      • 7.3.3.4 Target Customers
      • 7.3.3.5 Key Personal
      • 7.3.3.6 Analyst View
    • 7.3.4 Zimmer Biomet Holdings, Inc.
      • 7.3.4.1 Overview
      • 7.3.4.2 Top Products/Product Portfolio
      • 7.3.4.3 Top Competitors
      • 7.3.4.4 Target Customers
      • 7.3.4.5 Key Personal
      • 7.3.4.6 Analyst View
    • 7.3.5 Medical Microinstruments, Inc.
      • 7.3.5.1 Overview
      • 7.3.5.2 Top Products/Product Portfolio
      • 7.3.5.3 Top Competitors
      • 7.3.5.4 Target Customers
      • 7.3.5.5 Key Personal
      • 7.3.5.6 Analyst View
    • 7.3.6 Monteris Medical Corporation
      • 7.3.6.1 Overview
      • 7.3.6.2 Top Products/Product Portfolio
      • 7.3.6.3 Top Competitors
      • 7.3.6.4 Target Customers
      • 7.3.6.5 Key Personal
      • 7.3.6.6 Analyst View
    • 7.3.7 Medtronic plc
      • 7.3.7.1 Overview
      • 7.3.7.2 Top Products/Product Portfolio
      • 7.3.7.3 Top Competitors
      • 7.3.7.4 Target Customers
      • 7.3.7.5 Key Personal
      • 7.3.7.6 Analyst View
    • 7.3.8 Accuray Incorporated
      • 7.3.8.1 Overview
      • 7.3.8.2 Top Products/Product Portfolio
      • 7.3.8.3 Top Competitors
      • 7.3.8.4 Target Customers
      • 7.3.8.5 Key Personal
      • 7.3.8.6 Analyst View
    • 7.3.9 AiM Medical Robotics
      • 7.3.9.1 Overview
      • 7.3.9.2 Top Products/Product Portfolio
      • 7.3.9.3 Top Competitors
      • 7.3.9.4 Target Customers
      • 7.3.9.5 Key Personal
      • 7.3.9.6 Analyst View
    • 7.3.10 KUKA AG (Midea Group)
      • 7.3.10.1 Overview
      • 7.3.10.2 Top Products/Product Portfolio
      • 7.3.10.3 Top Competitors
      • 7.3.10.4 Target Customers
      • 7.3.10.5 Key Personal
      • 7.3.10.6 Analyst View
    • 7.3.11 Beijing Baihui Weikang Technology Co., Ltd.
      • 7.3.11.1 Overview
      • 7.3.11.2 Top Products/Product Portfolio
      • 7.3.11.3 Top Competitors
      • 7.3.11.4 Target Customers
      • 7.3.11.5 Key Personal
      • 7.3.11.6 Analyst View
    • 7.3.12 Brain Navi Biotechnology Co. Ltd
      • 7.3.12.1 Overview
      • 7.3.12.2 Top Products/Product Portfolio
      • 7.3.12.3 Top Competitors
      • 7.3.12.4 Target Customers
      • 7.3.12.5 Key Personal
      • 7.3.12.6 Analyst View
    • 7.3.13 Beijing Tinavi Medical Technologies Co., Ltd.
      • 7.3.13.1 Overview
      • 7.3.13.2 Top Products/Product Portfolio
      • 7.3.13.3 Top Competitors
      • 7.3.13.4 Target Customers
      • 7.3.13.5 Key Personal
      • 7.3.13.6 Analyst View

8 Research Methodology

  • 8.1 Data Sources
    • 8.1.1 Primary Data Sources
    • 8.1.2 Secondary Data Sources
    • 8.1.3 Data Triangulation
  • 8.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Robotic Neurosurgery Market (by Scenario), $Million, 2024, 2028, and 2035
  • Figure 2: Global Robotic Neurosurgery Market, $Million, 2023 and 2035
  • Figure 3: Robotic Neurosurgery Market (by End User), $Million, 2023, 2028, and 2035
  • Figure 4: Robotic Neurosurgery Market (by Product Type), $Million, 2023, 2028, and 2035
  • Figure 5: Robotic Neurosurgery Market (by Application), $Million, 2023, 2028, and 2035
  • Figure 6: Robotic Neurosurgery Literature Published, January 2015 to April 2025
  • Figure 7: Robotic Neurosurgery Market Segmentation
  • Figure 8: Supply Chain and Risks within the Supply Chain
  • Figure 9: FDA Classification
  • Figure 10: EU Classification
  • Figure 11: NHS Classification
  • Figure 12: Japan Federation of Medical Devices Associations (JFMDA) Classification
  • Figure 13: NMPA Classification
  • Figure 14: Organization of the Health System in the U.S.
  • Figure 15: Global Robotic Neurosurgery Market, Patent Analysis (by Country), January 2019-April 2025
  • Figure 16: Global Robotic Neurosurgery Market, Patent Analysis (by Year), January 2019-April 2025
  • Figure 17: Impact Analysis of Market Navigating Factors, 2024-2035
  • Figure 18: Global Incidences of Neurological Disorders, Thousands, 2018-2021
  • Figure 19: Global Prevalence of Neurological Disorders (by Type of Neurological Disease), Thousands, 1990-2019
  • Figure 20: Prevalence of Parkinson's Disease, Region (2016-2021)
  • Figure 21: Timeline of the FDA Approvals for Various Robotic Neurosurgery Systems
  • Figure 22: Global Robotic Neurosurgery Market (by Product Type), $Million, 2023, 2028, and 2035
  • Figure 23: Global Robotic Neurosurgery Market, Robotic Systems, $Million, 2023-2035
  • Figure 24: Global Robotic Neurosurgery Market, Instruments and Accessories, $Million, 2023-2035
  • Figure 25: Global Robotic Neurosurgery Market, Services, $Million, 2023-2035
  • Figure 26: Global Robotic Neurosurgery Market (by Application), 2023, 2028, and 2035
  • Figure 27: Global Robotic Neurosurgery Market, Spinal Neurosurgery,$Million, 2023-2035
  • Figure 28: Global Robotic Neurosurgery Market, Cranial Neurosurgery,$Million, 2023-2035
  • Figure 29: Global Robotic Neurosurgery Market (by End User), $Million, 2023, 2028, and 2035
  • Figure 30: Global Robotic Neurosurgery Market, Hospitals, $Million, 2023-2035
  • Figure 31: Global Robotic Neurosurgery Market, Ambulatory Surgical Centers, $Million, 2023-2035
  • Figure 32: North America Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 33: North America Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 34: North America Robotic Neurosurgery Market, Installed Base, 2023-2035
  • Figure 35: North America Robotic Neurosurgery Market, Unit Sold, 2023-2035
  • Figure 36: Incidences of Neurological Disorders in U.S., 2018-2021
  • Figure 37: U.S. Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 38: U.S. Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 39: Incidences of Neurological Disorders in Canada, 2018-2021
  • Figure 40: Canada Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 41: Canada Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 42: Europe Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 43: Europe Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 44: Europe Robotic Neurosurgery Market, Installed Base, 2023-2035
  • Figure 45: Europe Robotic Neurosurgery Market, Unit Sold, 2023-2035
  • Figure 46: Incidences of Neurological Disorders in Germany, 2018-2021
  • Figure 47: Germany Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 48: Germany Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 49: Incidences of Neurological Disorders in France, 2018-2021
  • Figure 50: France Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 51: France Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 52: Incidences of Neurological Disorders in Italy, 2018-2021
  • Figure 53: Italy Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 54: Italy Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 55: Incidences of Neurological Disorders in Spain, 2018-2021
  • Figure 56: Spain Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 57: Spain Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 58: Incidences of Neurological Disorders in U.K., 2018-2021
  • Figure 59: U.K. Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 60: U.K. Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 61: Rest-of-Europe Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 62: Rest-of-Europe Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 63: Asia-Pacific Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 64: Asia-Pacific Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 65: Asia-Pacific Robotic Neurosurgery Market, Installed Base, 2023-2035
  • Figure 66: Asia-Pacific Robotic Neurosurgery Market, Unit Sold, 2023-2035
  • Figure 67: Incidences of Neurological Disorders in China, 2018-2021
  • Figure 68: China Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 69: China Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 70: Incidences of Neurological Disorders in Japan, 2018-2021
  • Figure 71: Japan Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 72: Japan Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 73: Incidences of Neurological Disorders in India, 2018-2021
  • Figure 74: India Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 75: India Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 76: Incidences of Neurological Disorders in Australia, 2018-2021
  • Figure 77: Australia Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 78: Australia Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 79: Incidences of Neurological Disorders in South Korea, 2018-2021
  • Figure 80: South Korea Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 81: South Korea Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 82: Rest-of-Asia-Pacific Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 83: Rest-of-Asia-Pacific Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 84: Rest-of-the-World Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 85: Rest-of-the-World Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 86: Rest-of-the-World Robotic Neurosurgery Market, Installed Base, 2023-2035
  • Figure 87: Rest-of-the-World Robotic Neurosurgery Market, Unit Sold, 2023-2035
  • Figure 88: Strategic Initiatives, January 2022-April 2025
  • Figure 89: Data Triangulation
  • Figure 90: Top-Down and Bottom-Up Approach
  • Figure 91: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Competitive Landscape Snapshot
  • Table 3: Robotic Neurosurgery Market Trend Analysis
  • Table 4: Some of the Partnerships and Collaborations in the Global Robotic Neurosurgery Market
  • Table 5: Some of the Product Launch and Regulatory Approvals in the Global Robotic Neurosurgery Market
  • Table 6: FDA Classification Details for Several Prominent Robotic Neurosurgery Systems
  • Table 7: Medical Devices in Japan
  • Table 8: Regulatory Process in RoW
  • Table 9: Costs of Neurosurgery Robotic Systems
  • Table 10: Funding Scenario of Neurosurgery Robotic Systems
  • Table 11: Comparison of Robotic Neurosurgical Procedures Over Conventional Open Surgical Procedures
  • Table 12: Comparison Between Various Navigation Systems Cost Breakdown of Robotic Neurosurgery Systems
  • Table 13: Global Robotic Neurosurgery Market, Robotic Systems (by Company), $Million, 2023-2035
  • Table 14: Global Robotic Neurosurgery Market, Instruments and Accessories (by Company), $Million, 2023-2035
  • Table 15: Global Robotic Neurosurgery Market, Services (by Company), $Million, 2023-2035
  • Table 16: Robotic Neurosurgery Market (by Region), $Million, 2023-2035
  • Table 17: North America Robotic Neurosurgery Market (by Product Type), $Million, 2023-2035
  • Table 18: Incidences of Neurological Disorders in U.S., By Disease Type, 2018-2021
  • Table 19: Incidences of Neurological Disorders in Canada, By Disease Type, 2018-2021
  • Table 20: Europe Robotic Neurosurgery Market (by Product Type), $Million, 2023-2035
  • Table 21: Incidences of Neurological Disorders in Germany, By Disease Type, 2018-2021
  • Table 22: Incidences of Neurological Disorders in France, By Disease Type, 2018-2021
  • Table 23: Incidences of Neurological Disorders in Italy, By Disease Type, 2018-2021
  • Table 24: Incidences of Neurological Disorders in Spain, By Disease Type, 2018-2021
  • Table 25: Incidences of Neurological Disorders in U.K., By Disease Type, 2018-2021
  • Table 26: Asia-Pacific Robotic Neurosurgery Market (by Product Type), $Million, 2023-2035
  • Table 27: Incidences of Neurological Disorders in China, By Disease Type, 2018-2021
  • Table 28: Incidences of Neurological Disorders in Japan, By Disease Type, 2018-2021
  • Table 29: Incidences of Neurological Disorders in India, By Disease Type, 2018-2021
  • Table 30: Incidences of Neurological Disorders in Australia, By Disease Type, 2018-2021
  • Table 31: Incidences of Neurological Disorders in South Korea, By Disease Type, 2018-2021
  • Table 32: Rest-of-the-World Robotic Neurosurgery Market (by Product Type), $Million, 2023-2035
  • Table 33: Global Robotic Neurosurgery Market, Product Benchmarking (by Product)
  • Table 34: Key Strategies, January 2022-April 2025